share_log

Those Who Invested in Merit Medical Systems (NASDAQ:MMSI) Three Years Ago Are up 43%

Those Who Invested in Merit Medical Systems (NASDAQ:MMSI) Three Years Ago Are up 43%

三年前投资Merit Medical Systems(纳斯达克股票代码:MMSI)的人上涨了43%
Simply Wall St ·  2023/11/15 08:59

By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. For example, the Merit Medical Systems, Inc. (NASDAQ:MMSI) share price is up 43% in the last three years, clearly besting the market return of around 13% (not including dividends). On the other hand, the returns haven't been quite so good recently, with shareholders up just 5.1%.

通过购买指数基金,您可以轻松地大致匹配市场回报。但是,如果你以诱人的价格收购优秀的企业,你的投资组合回报可能会超过平均市场回报。例如,Merit Medical Systems, Inc.(纳斯达克股票代码:MMSI)的股价在过去三年中上涨了43%,显然超过了约13%的市场回报率(不包括股息)。另一方面,最近的回报率不太好,股东仅上涨了5.1%。

So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.

因此,让我们调查一下,看看公司的长期表现是否与基础业务的进展一致。

See our latest analysis for Merit Medical Systems

查看我们对 Merit 医疗系统的最新分析

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

不可否认,市场有时是有效的,但价格并不总是能反映潜在的业务表现。研究市场情绪如何随着时间的推移而变化的一种方法是研究公司股价与其每股收益(EPS)之间的相互作用。

Merit Medical Systems became profitable within the last three years. That would generally be considered a positive, so we'd expect the share price to be up.

Merit Medical Systems在过去三年内实现了盈利。这通常被认为是积极的,因此我们预计股价会上涨。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

该公司的每股收益(随着时间的推移)如下图所示(点击查看确切数字)。

earnings-per-share-growth
NasdaqGS:MMSI Earnings Per Share Growth November 15th 2023
纳斯达克:MMSI 每股收益增长 2023 年 11 月 15 日

It is of course excellent to see how Merit Medical Systems has grown profits over the years, but the future is more important for shareholders. Take a more thorough look at Merit Medical Systems' financial health with this free report on its balance sheet.

当然,很高兴看到Merit Medical Systems多年来如何增加利润,但未来对股东来说更为重要。通过这份免费的资产负债表报告,更全面地了解Merit Medical Systems的财务状况。

A Different Perspective

不同的视角

Merit Medical Systems provided a TSR of 5.1% over the last twelve months. But that was short of the market average. The silver lining is that the gain was actually better than the average annual return of 5% per year over five year. This suggests the company might be improving over time. Before spending more time on Merit Medical Systems it might be wise to click here to see if insiders have been buying or selling shares.

在过去的十二个月中,Merit Medical Systems提供的股东总回报率为5.1%。但这还低于市场平均水平。一线希望是,收益实际上好于五年内每年5%的平均年回报率。这表明随着时间的推移,该公司可能会有所改善。在花更多时间研究Merit Medical Systems之前,明智的做法是点击此处查看内部人士是否在买入或卖出股票。

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

对于那些喜欢寻找中奖投资的人来说,这份最近有内幕收购的成长型公司的免费名单可能只是门票。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发